开盘$13.94
昨收$14.12
当日区间$13.32 – $14.13
成交量871.9K
市值$1.04B
市盈率（TTM）78.9
股息率–
IART 相关新闻
匹配 Integra Lifesciences 或代码 IART 的头条新闻，按最新排序。
- J.P. Morgan Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $17 正面
- Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $19
- BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $18 负面
- Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $18 正面
- Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $19 正面
- BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19
- Argus Research Upgrades Integra Lifesciences(IART.US) to Buy Rating, Announces Target Price $25 正面
- Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $15 正面
- Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $11 正面
- Citi Upgrades Integra Lifesciences(IART.US) to Hold Rating, Raises Target Price to $16 正面
- BofA Securities Initiates Integra Lifesciences(IART.US) With Sell Rating
- Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)
- Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $9
- Argus Research Downgrades Integra Lifesciences(IART.US) to Hold Rating 负面
- Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $12 负面
暂无评论——快来第一个聊聊 IART。
登录后参与讨论。